These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 26995171)

  • 21. FDA Experience With Regulation of Naloxone Products to Address the Opioid Crisis and Opportunities for Leveraging Scientific Engagement.
    Amur S; Xu Y; Hertz S; Clingman C
    Clin Pharmacol Ther; 2021 Mar; 109(3):569-572. PubMed ID: 33241562
    [No Abstract]   [Full Text] [Related]  

  • 22. Pharmacokinetic Properties and Human Use Characteristics of an FDA-Approved Intranasal Naloxone Product for the Treatment of Opioid Overdose.
    Krieter P; Chiang N; Gyaw S; Skolnick P; Crystal R; Keegan F; Aker J; Beck M; Harris J
    J Clin Pharmacol; 2016 Oct; 56(10):1243-53. PubMed ID: 27145977
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development and implementation of procedures for outpatient naloxone prescribing at a large academic medical center.
    Zschoche JH; Nesbit S; Murtaza U; Sowell A; Waldfogel JM; Arwood N; Rush J; McNamara L; Swarthout M; Nesbit T; Ortmann M
    Am J Health Syst Pharm; 2018 Nov; 75(22):1812-1820. PubMed ID: 30076167
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A systematic review of community opioid overdose prevention and naloxone distribution programs.
    Clark AK; Wilder CM; Winstanley EL
    J Addict Med; 2014; 8(3):153-63. PubMed ID: 24874759
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Take home naloxone for Ireland.
    Bury G
    Ir Med J; 2015 Mar; 108(3):70. PubMed ID: 25876295
    [No Abstract]   [Full Text] [Related]  

  • 26. Emergency department naloxone distribution: a Rhode Island department of health, recovery community, and emergency department partnership to reduce opioid overdose deaths.
    Samuels E
    R I Med J (2013); 2014 Oct; 97(10):38-9. PubMed ID: 25271659
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Brief overdose education is sufficient for naloxone distribution to opioid users.
    Behar E; Santos GM; Wheeler E; Rowe C; Coffin PO
    Drug Alcohol Depend; 2015 Mar; 148():209-12. PubMed ID: 25595053
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overdose Education and Naloxone Distribution in the San Francisco County Jail.
    Wenger LD; Showalter D; Lambdin B; Leiva D; Wheeler E; Davidson PJ; Coffin PO; Binswanger IA; Kral AH
    J Correct Health Care; 2019 Oct; 25(4):394-404. PubMed ID: 31672075
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Naloxone administration for suspected opioid overdose: An expanded scope of practice by a basic life support collegiate-based emergency medical services agency.
    Jeffery RM; Dickinson L; Ng ND; DeGeorge LM; Nable JV
    J Am Coll Health; 2017 Apr; 65(3):212-216. PubMed ID: 28059635
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expanding access to naloxone in the United States.
    Doyon S; Aks SE; Schaeffer S; ; ;
    Clin Toxicol (Phila); 2014 Dec; 52(10):989-92. PubMed ID: 25283253
    [No Abstract]   [Full Text] [Related]  

  • 31. Cost-Effectiveness of Intranasal Naloxone Distribution to High-Risk Prescription Opioid Users.
    Acharya M; Chopra D; Hayes CJ; Teeter B; Martin BC
    Value Health; 2020 Apr; 23(4):451-460. PubMed ID: 32327162
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factors Associated With Participation in an Emergency Department-Based Take-Home Naloxone Program for At-Risk Opioid Users.
    Kestler A; Buxton J; Meckling G; Giesler A; Lee M; Fuller K; Quian H; Marks D; Scheuermeyer F
    Ann Emerg Med; 2017 Mar; 69(3):340-346. PubMed ID: 27745764
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rapid widespread distribution of intranasal naloxone for overdose prevention.
    Madah-Amiri D; Clausen T; Lobmaier P
    Drug Alcohol Depend; 2017 Apr; 173():17-23. PubMed ID: 28182982
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Rhode Island community responds to opioid overdose deaths.
    Bowman S; Engelman A; Koziol J; Mahoney L; Maxwell C; McKenzie M
    R I Med J (2013); 2014 Oct; 97(10):34-7. PubMed ID: 25271658
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Distribution of naloxone to prevent death from heroin overdose. Study of opioid dependent patients' attitudes to be part of the antidote program].
    Håkansson A; Vedin A; Wallin C; Kral AH
    Lakartidningen; 2013 Jul 17-Aug 6; 110(29-31):1340-2. PubMed ID: 23980443
    [No Abstract]   [Full Text] [Related]  

  • 36. Working together: Expanding the availability of naloxone for peer administration to prevent opioid overdose deaths in the Australian Capital Territory and beyond.
    Lenton S; Dietze P; Olsen A; Wiggins N; McDonald D; Fowlie C
    Drug Alcohol Rev; 2015 Jul; 34(4):404-11. PubMed ID: 25272281
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Saved by the nose: bystander-administered intranasal naloxone hydrochloride for opioid overdose.
    Doe-Simkins M; Walley AY; Epstein A; Moyer P
    Am J Public Health; 2009 May; 99(5):788-91. PubMed ID: 19363214
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intranasal naloxone for treatment of opioid overdose.
    Med Lett Drugs Ther; 2014 Mar; 56(1438):21-2. PubMed ID: 24662159
    [No Abstract]   [Full Text] [Related]  

  • 39. Naloxone without the needle - systematic review of candidate routes for non-injectable naloxone for opioid overdose reversal.
    Strang J; McDonald R; Alqurshi A; Royall P; Taylor D; Forbes B
    Drug Alcohol Depend; 2016 Jun; 163():16-23. PubMed ID: 26996745
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Naloxone as a technology of solidarity: history of opioid overdose prevention.
    Campbell ND
    CMAJ; 2019 Aug; 191(34):E945-E946. PubMed ID: 31451527
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.